BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16886063)

  • 1. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
    Fife BT; Griffin MD; Abbas AK; Locksley RM; Bluestone JA
    J Clin Invest; 2006 Aug; 116(8):2252-61. PubMed ID: 16886063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
    Prud'homme GJ; Chang Y; Li X
    Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte antigen 4 (CD152) regulates self-reactive T cells in BALB/c but not in the autoimmune NOD mouse.
    Piganelli JD; Poulin M; Martin T; Allison JP; Haskins K
    J Autoimmun; 2000 Mar; 14(2):123-31. PubMed ID: 10677243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
    Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
    Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
    Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
    Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated T cells can induce high levels of CTLA-4 expression on B cells.
    Kuiper HM; Brouwer M; Linsley PS; van Lier RA
    J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
    Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N
    Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.
    Sugita S; Streilein JW
    J Exp Med; 2003 Jul; 198(1):161-71. PubMed ID: 12835481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.